News
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Vascepa
Generic name
icosapent ethyl
Manufacturer
HLS Therapeutics
Indication(s)
Ischemic events in statin-treated patients
Project Number
SR0619-000
Call for patient input
2019-05-17
Patient input deadline
2019-07-09
Submit patient input
Submit
Register as Clin...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Benlysta
Generic name
belimumab
Manufacturer
GlaxoSmithKline Inc.
Indication(s)
Systemic lupus erythematosus
Project Number
SR0616-000
Call for patient input
2019-04-30
Patient input deadline
2019-06-19
Submit patient input
Submit
Register as Clinical Expert
Reg...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Verkazia
Generic name
cyclosporine
Manufacturer
Santen Inc.
Indication(s)
Severe vernal keratoconjunctivitis, pediatric (≥4 years)
Project Number
SR0615-000
Call for patient input
2019-04-23
Patient input deadline
2019-06-12
Submit patient input
Submit
Register ...
See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised following a request for reconsideration by manufacturers...
